Rapport Therapeutics

Acquisition, funding and merger involving Rapport Therapeutics.

• Rapport Therapeutics has just announced a $150 Million fundraising (posted on August 23 2023).

View the org chart displaying its 20 main executives

Most searched biographies at Rapport Therapeutics

• Abraham Ceesay, Chief Executive Officer
• Jeff Tong, Director
• Steve Paul, Chairman of the Board

Popular executive movements at Rapport Therapeutics

• John Maraganore has joined the company as Director  (posted on March 19 2024).
• Kathy Wilkinson has joined the company as Chief People Officer  (posted on February 29 2024).
• Terry-Ann Burrell has joined the company as Director  (posted on January 17 2024).

Click here to view some more movements at Rapport Therapeutics

Create your alert
to follow the executive moves at Rapport Therapeutics.

Rapport Therapeutics has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Rapport Therapeutics

• News and Presentations » Rapport Therapeutics
• News » Rapport Therapeutics

Social media about Rapport Therapeutics

• Rapport Therapeutics on Wikipedia, Google News & Yahoo Finance
• Rapport Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Abraham Ceesay

Call Rapport Therapeutics at +1 857...

View the org chart

Register to receive your alert

Report an error